Literature DB >> 12120230

Update of familial pancreatic cancer in Germany.

D K Bartsch1, M Sina-Frey, A Ziegler, S A Hahn, E Przypadlo, R Kress, B Gerdes, H Rieder.   

Abstract

BACKGROUND/AIMS: The prevalence of familial pancreatic cancer (FPC) and the characteristics of FPC have not yet been well investigated in the German population. Therefore, a German case collection for FPC was established in July 1999 to collect and evaluate data on FPC families.
METHODS: The prevalence of pancreatic cancer (PC) as well as other tumours and diseases was studied in families with at least 2 first-degree relatives with histologically confirmed PC, and in families of patients with PC and a first-degree relative with malignant melanoma. All participating family members were genetically counselled and evaluated by a standardised questionnaire.
RESULTS: In an 18-month period, 73 independent kindreds with potential FPC contacted the national case collection. So far, 20 kindreds have fulfilled the criteria for FPC and have undergone complete workups. Most families revealed an autosomal dominant pattern of inheritance. Twelve families revealed an isolated accumulation of PC. Importantly, in 8 of 20 (35%) families, additional tumour types such as melanoma, breast and prostate cancer occurred.
CONCLUSION: The observed phenotypic heterogeneity indicates an association with predisposing tumour suppressor genes p16 and BRCA2 in up to 30% of FPC families. Mutation analysis of these candidate genes might lead to the identification of the predisposing gene defect in a proportion of FPC families.

Entities:  

Mesh:

Year:  2001        PMID: 12120230     DOI: 10.1159/000055853

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  16 in total

Review 1.  Familial pancreatic cancer--current knowledge.

Authors:  Detlef K Bartsch; Thomas M Gress; Peter Langer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-06-05       Impact factor: 46.802

Review 2.  Familial pancreatic cancer--status quo.

Authors:  Volker Fendrich; Peter Langer; Detlef K Bartsch
Journal:  Int J Colorectal Dis       Date:  2013-08-16       Impact factor: 2.571

Review 3.  [Prophylactic pancreas surgery].

Authors:  P Langer; M Rothmund; D K Bartsch
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

Review 4.  Hereditary pancreatic cancer: molecular bases and their application in diagnosis and clinical management: a guideline of the TTD group.

Authors:  P Pérez Segura; C Guillén Ponce; T Ramón Y Cajal; R Serrano Blanch; E Aranda
Journal:  Clin Transl Oncol       Date:  2012-07-19       Impact factor: 3.405

5.  German national case collection for familial pancreatic cancer (FaPaCa): ten years experience.

Authors:  Ralph Schneider; Emily P Slater; Mercede Sina; Nils Habbe; Volker Fendrich; Elvira Matthäi; Peter Langer; Detlef K Bartsch
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

6.  Low frequency of CHEK2 mutations in familial pancreatic cancer.

Authors:  Detlef K Bartsch; Kristina Krysewski; Mercedes Sina-Frey; Volker Fendrich; Harald Rieder; Peter Langer; Ralf Kress; Margarete Schneider; Stephan A Hahn; Emily P Slater
Journal:  Fam Cancer       Date:  2006-07-20       Impact factor: 2.375

7.  CDKN2A germline mutations in familial pancreatic cancer.

Authors:  Detlef K Bartsch; Mercedes Sina-Frey; Sven Lang; Anja Wild; Berthold Gerdes; Peter Barth; Ralf Kress; Robert Grützmann; Mario Colombo-Benkmann; Andreas Ziegler; Stephan A Hahn; Matthias Rothmund; Harald Rieder
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

8.  Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families.

Authors:  Emily P Slater; Peter Langer; Volker Fendrich; Nils Habbe; Brunhilde Chaloupka; Elvira Matthäi; Mercedes Sina; Stephan A Hahn; Detlef K Bartsch
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

Review 9.  [Hereditary pancreatic cancer].

Authors:  N Habbe; P Langer; D K Bartsch
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955

Review 10.  Familial pancreatic cancer.

Authors:  Harald Rieder; Detlef K Bartsch
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.